SANOFI INDIA
|
The Current P/S Ratio of SANOFI INDIA is 4.30.
| Share Price | ₹3,433.1 | Apr 27,2026 |
| Market Cap | ₹7,896.0 Cr | |
| Sales-TTM | ₹1,837.4 Cr | TTM-Standalone Results |
| Price/Sales | 4.30x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,896.0 Cr] as on Apr 27,2026
(/) Sales [ ₹1,837.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.30x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay '4.30 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI INDIA
PS Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2025 to Dec2021 averaged 6.48x.
- SANOFI INDIA 's operated at median p/e ratio of 6.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 9.3x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2022 of 4.86x.
How does SANOFI INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI INDIA | 1,837.4 | 4.30 | 7,896.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.32 | 415,997.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.67 | 171,900.0 |
| CIPLA LTD | 28,351.1 | 3.75 | 106,397.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.21 | 142,804.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.21 | 111,389.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.72 | 93,546.9 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.59 | 93,765.9 |
| LUPIN LTD | 26,150.5 | 4.06 | 106,260.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.48 | 82,337.3 |
| ABBOTT INDIA LTD | 6,824.1 | 7.93 | 54,085.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.48x |
| Max industry PS | 16.67x |
| Median industry PS | 4.30x |
| Average industry PS | 6.48x |
You may also like the below Video Courses